Disclosure NewswireTMiCrowdNewswire - Aug 31, 2016
MISGAV, ISRAEL – The Trendlines Group Ltd. (SGX: 42T, OTCQX: TRNLY), an innovation investment and commercialization company focused on technology in the medical and agricultural fields, announces that the Company has qualified to have its American Depositary Receipts (ADRs) trade on the OTCQX® Best Market. Trendlines will maintain its primary listing on the Singapore Exchange (SGX) and will begin trading today under the ADR symbol TRNLY.
Each Trendlines ADR represents 50 ordinary shares. Investors can find current financial disclosure and real-time Level 2 quotes for the company on www.otcmarkets.com. BNY Mellon has been appointed to act as the Principal American Liaison (“PAL”) in connection with sponsoring the Company’s securities on the OTCQX.
Commenting on the trading approval for the Trendlines ADRs, Steve Rhodes, Chairman and CEO of Trendlines, said, “We are excited to be trading on the OTCQX, allowing us to raise the profile of The Trendlines Group in the North American investment community. We are fortunate to have a strong shareholder base in North America, including those who invested in Trendlines prior to our IPO in Singapore in November of 2016. This ADR program creates a broader secondary market for the Company’s securities, and enables U.S. investors to trade more easily in the Company’s securities. We thank BNY Mellon and OTC Markets for their support and assistance through this process, and we look forward to updating the investment community as we move forward.”
The Trendlines Group is an innovation commercialization company that invents, discovers, invests in, and incubates innovation-based medical and agricultural technologies to fulfill its mission to improve the human condition. As intensely hands-on investors, Trendlines is involved in all aspects of its portfolio companies from technology development to business building. The Trendlines Group is traded on the Singapore Stock Exchange (SGX: 42T) and in the United States as an American Depositary Receipt (ADR) on the OTCQX (OTCQX: TRNLY).
Statements in this press release that are not statements of historical or current fact constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the Company’s actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as “believes,” “belief,” “expects,” “expect,” “intends,” “intend,” “anticipate,” “anticipates,” “plans,” “plan,” to be uncertain and forward looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company’s filings with the Securities and Exchange Commission.
Investor Contact Information
Judith Kleinman, Director, Investor Relations & Corporate Communications
Adam Holdsworth, Managing Director of Investor Relations